Specify a stock or a cryptocurrency in the search bar to get a summary
LENSAR Inc
LNSRLENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida. Address: 2800 Discovery Drive, Orlando, FL, United States, 32826
Analytics
WallStreet Target Price
11 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures LNSR
Dividend Analytics LNSR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History LNSR
Stock Valuation LNSR
Financials LNSR
Results | 2019 | Dynamics |